198 related articles for article (PubMed ID: 26309225)
1. The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.
Rother S; Hundrieser J; Pokoyski C; Kollrich S; Borns K; Blasczyk R; Poehnert D; Klempnauer J; Schwinzer R
PLoS One; 2015; 10(8):e0135682. PubMed ID: 26309225
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).
Kamishikiryo J; Fukuhara H; Okabe Y; Kuroki K; Maenaka K
J Biol Chem; 2011 Jul; 286(27):23823-30. PubMed ID: 21572041
[TBL] [Abstract][Full Text] [Related]
3. The killer cell lectin-like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantation.
Thude H; Rother S; Sterneck M; Klempnauer J; Nashan B; Schwinzer R; Koch M
HLA; 2018 Jan; 91(1):52-55. PubMed ID: 29111570
[TBL] [Abstract][Full Text] [Related]
4. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
Singleterry WL; Henderson H; Cruse JM
Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.
Lin YL; Lin SC
Clin Exp Med; 2017 Feb; 17(1):101-109. PubMed ID: 26590595
[TBL] [Abstract][Full Text] [Related]
6. High-level expression and purification of soluble form of human natural killer cell receptor NKR-P1 in HEK293S GnTI
Bláha J; Kalousková B; Skořepa O; Pažický S; Novák P; Vaněk O
Protein Expr Purif; 2017 Dec; 140():36-43. PubMed ID: 28757467
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
Mathew SO; Chaudhary P; Powers SB; Vishwanatha JK; Mathew PA
Oncotarget; 2016 Oct; 7(42):68650-68661. PubMed ID: 27626681
[TBL] [Abstract][Full Text] [Related]
8. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.
Germain C; Meier A; Jensen T; Knapnougel P; Poupon G; Lazzari A; Neisig A; Håkansson K; Dong T; Wagtmann N; Galsgaard ED; Spee P; Braud VM
J Biol Chem; 2011 Nov; 286(44):37964-37975. PubMed ID: 21930700
[TBL] [Abstract][Full Text] [Related]
9. Changes of frequency and expression level of CD161 in CD8
Park Y; Lim J; Kim SY; Kwon GC; Koo SH; Kim J
Microbiol Immunol; 2020 Jul; 64(7):532-539. PubMed ID: 32343447
[TBL] [Abstract][Full Text] [Related]
10. C-type lectin-like CD161 is not a co-signalling receptor in gluten-reactive CD4 + T cells.
Wyrożemski Ł; Sollid LM; Qiao SW
Scand J Immunol; 2021 Jun; 93(6):e13016. PubMed ID: 33368526
[TBL] [Abstract][Full Text] [Related]
11. Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.
Shen H; Zhang W; Abraham C; Cho JH
PLoS One; 2013; 8(3):e57746. PubMed ID: 23469228
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.
Aldemir H; Prod'homme V; Dumaurier MJ; Retiere C; Poupon G; Cazareth J; Bihl F; Braud VM
J Immunol; 2005 Dec; 175(12):7791-5. PubMed ID: 16339512
[TBL] [Abstract][Full Text] [Related]
13. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
Warrington KJ; Takemura S; Goronzy JJ; Weyand CM
Arthritis Rheum; 2001 Jan; 44(1):13-20. PubMed ID: 11212151
[TBL] [Abstract][Full Text] [Related]
14. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.
Maggi L; Santarlasci V; Capone M; Peired A; Frosali F; Crome SQ; Querci V; Fambrini M; Liotta F; Levings MK; Maggi E; Cosmi L; Romagnani S; Annunziato F
Eur J Immunol; 2010 Aug; 40(8):2174-81. PubMed ID: 20486123
[TBL] [Abstract][Full Text] [Related]
15. Characterization of alternatively spliced transcript variants of CLEC2D gene.
Germain C; Bihl F; Zahn S; Poupon G; Dumaurier MJ; Rampanarivo HH; Padkjær SB; Spee P; Braud VM
J Biol Chem; 2010 Nov; 285(46):36207-15. PubMed ID: 20843815
[TBL] [Abstract][Full Text] [Related]
16. CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Duurland CL; Santegoets SJ; Abdulrahman Z; Loof NM; Sturm G; Wesselink TH; Arens R; Boekestijn S; Ehsan I; van Poelgeest MIE; Finotello F; Hackl H; Trajanoski Z; Ten Dijke P; Braud VM; Welters MJP; van der Burg SH
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039463
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities.
Takahashi T; Dejbakhsh-Jones S; Strober S
J Immunol; 2006 Jan; 176(1):211-6. PubMed ID: 16365412
[TBL] [Abstract][Full Text] [Related]
19. LLT1-CD161 Interaction in Cancer: Promises and Challenges.
Braud VM; Meghraoui-Kheddar A; Elaldi R; Petti L; Germain C; Anjuère F
Front Immunol; 2022; 13():847576. PubMed ID: 35185935
[TBL] [Abstract][Full Text] [Related]
20. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages.
Fergusson JR; Smith KE; Fleming VM; Rajoriya N; Newell EW; Simmons R; Marchi E; Björkander S; Kang YH; Swadling L; Kurioka A; Sahgal N; Lockstone H; Baban D; Freeman GJ; Sverremark-Ekström E; Davis MM; Davenport MP; Venturi V; Ussher JE; Willberg CB; Klenerman P
Cell Rep; 2014 Nov; 9(3):1075-88. PubMed ID: 25437561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
